These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32063720)

  • 21. Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radiofrequency Ablation.
    Peng Z; Chen S; Wei M; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Chen M; Qian G; Kuang M
    Radiology; 2018 May; 287(2):705-714. PubMed ID: 29390197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined endovascular brachytherapy, sorafenib, and transarterial chemobolization therapy for hepatocellular carcinoma patients with portal vein tumor thrombus.
    Zhang ZH; Liu QX; Zhang W; Ma JQ; Wang JH; Luo JJ; Liu LX; Yan ZP
    World J Gastroenterol; 2017 Nov; 23(43):7735-7745. PubMed ID: 29209114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocellular Carcinoma With Portal Vein Tumor Thrombus Treated With Transarterial Chemoembolization and Sorafenib
    Hu HT; Luo JP; Cao GS; Li Z; Jiang M; Guo CY; Yuan H; Yao QJ; Geng X; Park JH; Cheng HT; Jiang L; Ma JL; Zhao Y; Li HL
    Front Oncol; 2021; 11():806907. PubMed ID: 35004330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Efficacy and Safety of TACE Combined with Microwave Ablation and TACE Combined with Cryoablation in the Treatment of Large Hepatocellular Carcinoma.
    Wang Y; Li W; Man W; Dong X; Luo Y; Zhang Y; Zhang Y; Dong C; Sun W; Yang P
    Comput Intell Neurosci; 2022; 2022():9783113. PubMed ID: 35795769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The PPRD score stratifies patients with hepatocellular carcinoma and portal vein tumor thrombus treated with sorafenib plus transarterial chemoembolization.
    Zhang Y; Miao H; Xie W; Jiang S; Song Z; Huang G; Fan W; Wang Y; Li J; Chen Y
    Eur Radiol; 2021 Jan; 31(1):232-243. PubMed ID: 32728770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Comparative Analysis of Efficacy of Apatinib Combined with Transarterial Chemoembolization and Transarterial Chemoembolization Alone in the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
    Sun T; Chen L; Kan X; Ren Y; Cao Y; Zhang W; Lu H; Zheng C
    J Oncol; 2022; 2022():1255133. PubMed ID: 35356254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microwave ablation of hepatocellular carcinoma with portal vein tumor thrombosis after transarterial chemoembolization: a prospective study.
    Long J; Zheng JS; Sun B; Lu N
    Hepatol Int; 2016 Jan; 10(1):175-84. PubMed ID: 26742761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiation Segmentectomy versus TACE Combined with Microwave Ablation for Unresectable Solitary Hepatocellular Carcinoma Up to 3 cm: A Propensity Score Matching Study.
    Biederman DM; Titano JJ; Bishay VL; Durrani RJ; Dayan E; Tabori N; Patel RS; Nowakowski FS; Fischman AM; Kim E
    Radiology; 2017 Jun; 283(3):895-905. PubMed ID: 27930089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocellular carcinoma with portal vein tumor thrombus: treatment with transarterial chemoembolization combined with sorafenib--a retrospective controlled study.
    Zhu K; Chen J; Lai L; Meng X; Zhou B; Huang W; Cai M; Shan H
    Radiology; 2014 Jul; 272(1):284-93. PubMed ID: 24708192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined radiofrequency ablation or microwave ablation with transarterial chemoembolization can increase efficiency in intermediate-stage hepatocellular carcinoma without more complication: a systematic review and meta-analysis.
    Yang Y; Yu H; Qi L; Liu C; Feng Y; Qi J; Li J; Zhu Q
    Int J Hyperthermia; 2022; 39(1):455-465. PubMed ID: 35271786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous Radiofrequency Ablation Combined With Transarterial Chemoembolization Plus Sorafenib for Large Hepatocellular Carcinoma Invading the Portal Venous System: A Prospective Randomized Study.
    Ding X; Sun W; Chen J; Li W; Shen Y; Guo X; Teng Y; Liu X; Sun S; Wei J; Li W; Chen H; Liu B
    Front Oncol; 2020; 10():578633. PubMed ID: 33194699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis].
    Luo J; Zheng JP; Shao GL; Wen S; Guo LW; Zeng H; Zhang L; Qian CY; Hao WY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):298-304. PubMed ID: 29996343
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of the Efficacy and Safety of Transarterial Chemoembolization Plus Microwave Ablation versus Surgical Resection in Patients with Solitary Large Hepatocellular Carcinoma: A Propensity Score-Matched Analysis.
    Zhang Y; Chen H; Chen S; Duan Y; Cheng L; Gao J; Li W
    J Hepatocell Carcinoma; 2022; 9():1309-1321. PubMed ID: 36567798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma.
    Wu FX; Chen J; Bai T; Zhu SL; Yang TB; Qi LN; Zou L; Li ZH; Ye JZ; Li LQ
    BMC Cancer; 2017 Sep; 17(1):645. PubMed ID: 28899349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transarterial chemoembolization (TACE) combined with apatinib versus TACE combined with sorafenib in advanced hepatocellular carcinoma patients: a multicenter retrospective study.
    Qiu Z; Shen L; Jiang Y; Qiu J; Xu Z; Shi M; Yu Z; Ma Y; He W; Zheng Y; Li B; Wang G; Yuan Y
    Ann Transl Med; 2021 Feb; 9(4):283. PubMed ID: 33708910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transarterial chemoembolization (TACE) combined with sorafenib versus TACE for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis.
    Zhang X; Wang K; Wang M; Yang G; Ye X; Wu M; Cheng S
    Oncotarget; 2017 Apr; 8(17):29416-29427. PubMed ID: 28177886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy of transarterial chemoembolization combined with microwave ablation for unresectable hepatocellular carcinoma: a systematic review and meta-analysis.
    Wang L; Ke Q; Lin N; Huang Q; Zeng Y; Liu J
    Int J Hyperthermia; 2019; 36(1):1288-1296. PubMed ID: 31852267
    [No Abstract]   [Full Text] [Related]  

  • 38. Combination transarterial chemoembolization and microwave ablation improves local tumor control for 3- to 5-cm hepatocellular carcinoma when compared with transarterial chemoembolization alone.
    Smolock AR; Cristescu MM; Hinshaw A; Woo KM; Wells SA; Ziemlewicz TJ; Lubner MG; Dalvie PS; Louis Hinshaw J; Brace CL; Ozkan OS; Lee FT; Laeseke P
    Abdom Radiol (NY); 2018 Sep; 43(9):2497-2504. PubMed ID: 29450606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemoembolization Plus Radiotherapy Versus Chemoembolization Plus Sorafenib for the Treatment of Hepatocellular Carcinoma Invading the Portal Vein: A Propensity Score Matching Analysis.
    Chu HH; Kim JH; Shim JH; Yoon SM; Kim PH; Alrashidi I
    Cancers (Basel); 2020 Apr; 12(5):. PubMed ID: 32365655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness and safety of sequential transarterial chemoembolization and microwave ablation for subphrenic hepatocellular carcinoma: A comprehensive evaluation.
    Zhu ZY; Qian Z; Qin ZQ; Xie B; Wei JZ; Yang PP; Yuan M
    World J Gastrointest Oncol; 2024 Jul; 16(7):2941-2951. PubMed ID: 39072162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.